Viatris (VTRS) Non-Current Assets (2019 - 2026)
Viatris (VTRS) recorded quarterly Non-Current Assets of $25.9 billion in Q1 2026, down 5.42% quarter-over-quarter from $27.4 billion in Q4 2025, and down 10.17% on a YoY basis from $28.9 billion in Q1 2025.
Viatris (VTRS) Non-Current Assets (2019 - 2026) Analysis & Trends
Viatris' Non-Current Assets history runs 8 years deep, the most recent figure standing at $25.9 billion for Q1 2026.
- In Q1 2026, Non-Current Assets fell 10.17% year-over-year to $25.9 billion; the TTM figure through Mar 2026 stood at $109.9 billion (down 14.0% YoY), while the FY2025 annual figure was $27.4 billion, down 14.31% from the prior year.
- Non-Current Assets was $25.9 billion for Q1 2026 at Viatris, down from $27.4 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $41.7 billion in Q1 2022 to a low of $25.9 billion in Q1 2026.
- Historically, Non-Current Assets has averaged $34.3 billion across 5 years, with a median of $34.4 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 7877260.0% in 2022, then declined 16.38% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $39.4 billion in 2022, then decreased by 11.88% to $34.7 billion in 2023, then declined by 7.86% to $32.0 billion in 2024, then dropped by 14.31% to $27.4 billion in 2025, then retreated by 5.42% to $25.9 billion in 2026.
- The last three Non-Current Assets figures came in at $25.9 billion (Q1 2026), $27.4 billion (Q4 2025), and $28.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Viatris | - | - | 1.16 Bn | 25.92 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.92 Bn |
| Dec 31, 2025 | 27.40 Bn |
| Sep 30, 2025 | 27.97 Bn |
| Jun 30, 2025 | 28.64 Bn |
| Mar 31, 2025 | 28.85 Bn |
| Dec 31, 2024 | 31.98 Bn |
| Sep 30, 2024 | 33.45 Bn |
| Jun 30, 2024 | 33.54 Bn |
| Mar 31, 2024 | 34.42 Bn |
| Dec 31, 2023 | 34.71 Bn |
| Sep 30, 2023 | 37.81 Bn |
| Jun 30, 2023 | 38.92 Bn |
| Mar 31, 2023 | 39.66 Bn |
| Dec 31, 2022 | 39.39 Bn |
| Sep 30, 2022 | 38.17 Bn |
| Jun 30, 2022 | 39.95 Bn |
| Mar 31, 2022 | 41.72 Bn |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 44.76 Bn |
| Jun 30, 2021 | 46.23 Bn |